Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 27

Results For "CAS"

2222 News Found

KIMS Hospitals launches Advanced Neurosciences Institute in Bengaluru
Healthcare | May 04, 2026

KIMS Hospitals launches Advanced Neurosciences Institute in Bengaluru

The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof


Health ministry releases new healthcare safety guidelines
Policy | May 04, 2026

Health ministry releases new healthcare safety guidelines

Week-long Fire Safety Week 2026 campaign focuses on strengthening fire prevention, preparedness, audits, and emergency response across hospitals and healthcare facilities


Kapil Dev inaugurates Digital PET-CT and Nuclear Medicine Department at Mahajan Imaging & Labs
Medical Device | May 04, 2026

Kapil Dev inaugurates Digital PET-CT and Nuclear Medicine Department at Mahajan Imaging & Labs

New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology


FDA advisory panel narrowly withholds support for AstraZeneca’s combo in breast cancer
News | May 04, 2026

FDA advisory panel narrowly withholds support for AstraZeneca’s combo in breast cancer

The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 3 to 6 against recommending camizestrant in combination with a CDK4/6 inhibitor


Gilead completes $7.8B Arcellx acquisition & takes full control of Myeloma CAR-T candidate
News | May 02, 2026

Gilead completes $7.8B Arcellx acquisition & takes full control of Myeloma CAR-T candidate

Under the terms, Arcellx shareholders received $115 per share in cash plus a non-transferable contingent value right


FDA grants breakthrough status to Laguna's mRNA blood test for schizophrenia diagnosis
News | May 02, 2026

FDA grants breakthrough status to Laguna's mRNA blood test for schizophrenia diagnosis

The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay


IMCD posts steady Q1 2026 performance with €130 million EBITA amid global uncertainty
Supply Chain | May 02, 2026

IMCD posts steady Q1 2026 performance with €130 million EBITA amid global uncertainty

The company posted revenue of €1,267 million, up 6% on a constant currency basis


Thermo Fisher to sell microbiology business in $1.075 billion deal with Astorg
News | May 02, 2026

Thermo Fisher to sell microbiology business in $1.075 billion deal with Astorg

The microbiology unit generated $645 million in revenue in 2025 and sits within Thermo Fisher’s Specialty Diagnostics segment


Dr Lal PathLabs posts strong Q4 FY26 results with 16.6% revenue growth & PAT at Rs. 132 Cr
News | May 02, 2026

Dr Lal PathLabs posts strong Q4 FY26 results with 16.6% revenue growth & PAT at Rs. 132 Cr

The company posted revenue of Rs. 703 crore in Q4 FY26


Patient-centric innovation driving fight against neglected diseases: Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi
interviews | May 01, 2026

Patient-centric innovation driving fight against neglected diseases: Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi

While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules